Discussion: Moderators: F. Peetoom, C.Th. Smit Sibinga
Dr. Bussel, I have two questions related to the data you presented on the usage of intravenous immunoglobulins for immune-deficiency patients. You mentioned that although the number of infections decreased, the number of hospital days increased. I would like to know if there was a specific reason for that discrepancy.
KeywordsFactor VIII African Swine Fever Virus Chronic Idiopathic Thrombocytopenic Purpura Intravenous Gamma Globulin Fibronectin Molecule
Unable to display preview. Download preview PDF.